Nuveen’s American Renal Associates Holdings, Inc ARA Stock Holding History

Nuveen’s Portfolio ARA Stock Details ARA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-59,590	Closed	-$412K	–	3427
2020 Q4	$412K	Sell	59,590 -6,453	-10%	-$73.5K	﹤0.01%	3085
2020 Q3	$456K	Buy	66,043 +4,144	+7%	+$27.2K	﹤0.01%	2979
2020 Q2	$403K	Buy	61,899 +105	+0.2%	+$678	﹤0.01%	2973
2020 Q1	$409K	Sell	61,794 -72	-0.1%	-$628	﹤0.01%	2842
2019 Q4	$641K	Sell	61,866 -356	-0.6%	-$3.04K	﹤0.01%	2846
2019 Q3	$394K	Sell	62,222 -988	-2%	-$7.36K	﹤0.01%	3005
2019 Q2	$470K	Buy	+63,210	New	+$417K	﹤0.01%	3027

Nuveen's ARA Position: Q1 2021 in Review

Nuveen sold out of American Renal Associates Holdings, Inc (ARA) in Q1 2021, closing a stake of 59,590 shares — an estimated $412K sold.

Nuveen first reported a position in ARA in Q2 2019 and held it in 7 quarters. The position peaked at $641K in Q4 2019. 0 funds tracked by Wall St. Rank hold ARA as of Q1 2021.

Nuveen reported no remaining American Renal Associates Holdings, Inc position as of Q1 2021 after selling out during the quarter.
Nuveen sold 59,590 American Renal Associates Holdings, Inc shares in Q1 2021, an estimated $412K.
Nuveen first reported a position in American Renal Associates Holdings, Inc in Q2 2019 and held it in 7 quarters.
Nuveen's American Renal Associates Holdings, Inc position peaked at $641K in Q4 2019.
0 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q1 2021.

Based on Nuveen's 13F filing for Q1 2021, filed 17 May 2021.